Market Definition:
• Inhalational anesthesia (IA) become the anesthetic of choice over Intravenous Anesthesia (IVA) among majority of healthcare practitioners, as it helps avoid excessive dosage and keeps the patient’s autonomic functions intact. IA has lower risk of delirium and is cost effective compared to IVA
• Inhalational anesthesia used for sedation as well as for the induction and maintenance of general anesthesia. The most common inhalational anesthetics are sevoflurane, desflurane, and nitrous oxide.
Market Overview and Trends
• To address the environmental impact of anesthetic gases, new technologies are being developed to scavenge them from hospital vents and recycle them.
• These anesthetic gases contribute up to 1.0% of global carbon dioxide emissions, leading to greater environmental damage.
• The major concern in using anesthetic gases is that patient use accounts for only 5.0% and the rest 95.0% is released into the atmosphere which contributes to global warming
Market Dynamics:
Factors Influencing the Market Growth:
• Rapid rise in aging population suffering from cancer, cardiovascular, spinal, orthopedic, respiratory, gastrointestinal, neurological, and other diseases and disorders is anticipated to drive the growth
• Increasing number of emergency cases and accidents are also expected to positively influence market growth
• Increasing number of orthopedic procedures such as ligament and other soft tissue repair procedures is also contributing to growth of the day care ambulatory surgeries, which is expected to boost usage of inhalation anesthesia.
Factors Restraining the Market Growth:
• Inhalational anesthetics cause respiratory depression, a decrease in arterial blood pressure and cerebral metabolic demand, and an increase in cerebral blood flow that may hinder the growth of the market.
Market Segmentation 2019-2029:
The inhalation anesthesia market is segmented on the product type, application, and geography.
Product Type
• Sevoflurane Market, 2019-2029
• Desflurane Market, 2019-2029
• Isoflurane Market, 2019-2029
Application
• Induction Market, 2019-2029
• Maintenance Market, 2019-2029
Geographic Breakdown
Focused regional forecasts and analysis explore the future opportunities:
• North America Market, 2019-2029
• Europe Market, 2019-2029
• Asia-Pacific Market, 2019-2029
• LAMEA Market, 2019-2029
Competitive Analysis:
• Research and development is the primary strategy adopted by the key players in the inhalation anesthesia market.
• These companies have developed various strategies and developments such as product launch, partnerships, mergers & acquisitions, joint venture, and collaborations.
• Baxter Healthcare is the only player with all the 3 products in its portfolio. AbbVie Inc. has sevoflurane and isoflurane in its portfolio. Piramal Healthcare presently has sevoflurane and isoflurane in its portfolio and may capture a significant market share of Baxter in the years to come owing to new product launches
Major Market Players:
Halocarbon Products Corporation; Hikima Pharmaceuticals PLC; Lunan Pharmaceutical Group Co. Ltd.; Piramal Enterprises Limited; Jiangsu Hengrui Medicine Co. Ltd.; Fresenius Kabi AG, and AbbVie Inc.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
1. Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Stakeholders
2. Research Methodology
2.1 Research Data
2.1.1 Primary Data
2.1.2 Secondary Data
2.2 Market Size Estimation
2.3 Research Assumptions
3. Executive Summary
4. Industry Insights
5. Global inhalation anesthesia Market – By Product Type
5.1 Sevoflurane
5.2 Isoflurane
5.3 Desflurane
6. Global inhalation anesthesia Market – By Application
6.1 Induction
6.2 Maintenance
7. Global inhalation anesthesia Market – By Geography
7.1 North America
7.1.1 US
7.1.2 Canada
7.2 Europe
7.2.1 Germany
7.2.2 France
7.2.3 UK
7.2.4 Rest of Europe
7.3 Asia-Pacific
7.3.1 Japan
7.3.2 China
7.3.3 India
7.3.4 Rest of APAC
7.4 LAMEA
7.4.1 Latin America
7.4.2 Middle East
7.4.3 Africa
8. Competitive Landscape
9. Company Profiles
9.1 Halocarbon Products Corporation
9.2 Hikima Pharmaceuticals PLC
9.3 Lunan Pharmaceutical Group Co. Ltd.
9.4 Piramal Enterprises Limited
9.5 Jiangsu Hengrui Medicine Co. Ltd.
9.6 Fresenius Kabi AG
9.7 AbbVie Inc.
9.8 Other Players
10. Appendix
List of Tables
Table 1 Global Inhalation Anesthesia Hypertension Market Revenue Analysis & Forecast, By Product Type, (US$ Mn AGR%, CAGR%), 2019-2029
Table 2 Global Inhalation Anesthesia Hypertension Market Revenue Analysis & Forecast, By Application, (US$ Mn AGR%, CAGR%), 2019-2029
Table 3 Global Inhalation Anesthesia Hypertension Market Revenue Analysis & Forecast, By Region, (US$ Mn AGR%, CAGR%), 2019-2029
Table 4 North America Inhalation Anesthesia Hypertension Market Revenue Analysis & Forecast, By Product Type, (US$ Mn AGR%, CAGR%), 2019-2029
Table 5 North America Inhalation Anesthesia Hypertension Market Revenue Analysis & Forecast, By Application, (US$ Mn AGR%, CAGR%), 2019-2029
Table 6 U.S. Inhalation Anesthesia Hypertension Market Revenue Analysis & Forecast, By Product Type, (US$ Mn AGR%, CAGR%), 2019-2029
Table 7 U.S. Inhalation Anesthesia Hypertension Market Revenue Analysis & Forecast, By Application, (US$ Mn AGR%, CAGR%), 2019-2029
Table 8 Canada Inhalation Anesthesia Hypertension Market Revenue Analysis & Forecast, By Product Type, (US$ Mn AGR%, CAGR%), 2019-2029
Table 9 Canada Inhalation Anesthesia Hypertension Market Revenue Analysis & Forecast, By Application, (US$ Mn AGR%, CAGR%), 2019-2029
Table 10 Europe Inhalation Anesthesia Hypertension Market Revenue Analysis & Forecast, By Product Type, (US$ Mn AGR%, CAGR%), 2019-2029
Table 11 Europe Inhalation Anesthesia Hypertension Market Revenue Analysis & Forecast, By Application, (US$ Mn AGR%, CAGR%), 2019-2029
Table 12 Germany Inhalation Anesthesia Hypertension Market Revenue Analysis & Forecast, By Product Type, (US$ Mn AGR%, CAGR%), 2019-2029
Table 13 Germany Inhalation Anesthesia Hypertension Market Revenue Analysis & Forecast, By Application, (US$ Mn AGR%, CAGR%), 2019-2029
Table 14 France Inhalation Anesthesia Hypertension Market Revenue Analysis & Forecast, By Product Type, (US$ Mn AGR%, CAGR%), 2019-2029
Table 15 France Inhalation Anesthesia Hypertension Market Revenue Analysis & Forecast, By Application, (US$ Mn AGR%, CAGR%), 2019-2029
Table 16 UK Inhalation Anesthesia Hypertension Market Revenue Analysis & Forecast, By Product Type, (US$ Mn AGR%, CAGR%), 2019-2029
Table 17 UK Inhalation Anesthesia Hypertension Market Revenue Analysis & Forecast, By Application, (US$ Mn AGR%, CAGR%), 2019-2029
Table 18 Rest of Europe Inhalation Anesthesia Hypertension Market Revenue Analysis & Forecast, By Product Type, (US$ Mn AGR%, CAGR%), 2019-2029
Table 19 Rest of Europe Inhalation Anesthesia Hypertension Market Revenue Analysis & Forecast, By Application, (US$ Mn AGR%, CAGR%), 2019-2029
Table 20 Asia-Pacific Inhalation Anesthesia Hypertension Market Revenue Analysis & Forecast, By Product Type, (US$ Mn AGR%, CAGR%), 2019-2029
Table 21 Asia-Pacific Inhalation Anesthesia Hypertension Market Revenue Analysis & Forecast, By Application, (US$ Mn AGR%, CAGR%), 2019-2029
Table 22 Japan Inhalation Anesthesia Hypertension Market Revenue Analysis & Forecast, By Product Type, (US$ Mn AGR%, CAGR%), 2019-2029
Table 23 Japan Inhalation Anesthesia Hypertension Market Revenue Analysis & Forecast, By Application, (US$ Mn AGR%, CAGR%), 2019-2029
Table 24 China Inhalation Anesthesia Hypertension Market Revenue Analysis & Forecast, By Product Type, (US$ Mn AGR%, CAGR%), 2019-2029
Table 25 China Inhalation Anesthesia Hypertension Market Revenue Analysis & Forecast, By Application, (US$ Mn AGR%, CAGR%), 2019-2029
Table 26 India Inhalation Anesthesia Hypertension Market Revenue Analysis & Forecast, By Product Type, (US$ Mn AGR%, CAGR%), 2019-2029
Table 27 India Inhalation Anesthesia Hypertension Market Revenue Analysis & Forecast, By Application, (US$ Mn AGR%, CAGR%), 2019-2029
Table 28 Rest of APAC Inhalation Anesthesia Hypertension Market Revenue Analysis & Forecast, By Product Type, (US$ Mn AGR%, CAGR%), 2019-2029
Table 29 Rest of APAC Inhalation Anesthesia Hypertension Market Revenue Analysis & Forecast, By Application, (US$ Mn AGR%, CAGR%), 2019-2029
Table 30 LAMEA Inhalation Anesthesia Hypertension Market Revenue Analysis & Forecast, By Product Type, (US$ Mn AGR%, CAGR%), 2019-2029
Table 31 LAMEA Inhalation Anesthesia Hypertension Market Revenue Analysis & Forecast, By Application, (US$ Mn AGR%, CAGR%), 2019-2029
Table 32 Latin America Inhalation Anesthesia Hypertension Market Revenue Analysis & Forecast, By Product Type, (US$ Mn AGR%, CAGR%), 2019-2029
Table 33 Latin America Inhalation Anesthesia Hypertension Market Revenue Analysis & Forecast, By Application, (US$ Mn AGR%, CAGR%), 2019-2029
Table 34 Middle East Inhalation Anesthesia Hypertension Market Revenue Analysis & Forecast, By Product Type, (US$ Mn AGR%, CAGR%), 2019-2029
Table 35 Middle East Inhalation Anesthesia Hypertension Market Revenue Analysis & Forecast, By Application, (US$ Mn AGR%, CAGR%), 2019-2029
Table 36 Africa Inhalation Anesthesia Hypertension Market Revenue Analysis & Forecast, By Product Type, (US$ Mn AGR%, CAGR%), 2019-2029
Table 37 Africa Inhalation Anesthesia Hypertension Market Revenue Analysis & Forecast, By Application, (US$ Mn AGR%, CAGR%), 2019-2029
List of Figures
Figure 1 Global Inhalation Anesthesia Hypertension Market: Segmentation
Figure 2 Global Inhalation Anesthesia Hypertension Market: Research Design
Figure 3 Global Inhalation Anesthesia Hypertension Market: 3 Drivers, Restraints, Opportunities, and Challenges
Figure 4 Global Inhalation Anesthesia Hypertension Market: By Product Type
Figure 5 Global Inhalation Anesthesia Hypertension Market: By Application
Figure 6 Global Inhalation Anesthesia Hypertension Market: By Region
Figure 7 North America Inhalation Anesthesia Hypertension Market: Market Snapshot
Figure 8 Europe Inhalation Anesthesia Hypertension Market: Market Snapshot
Figure 9 Asia-Pacific Inhalation Anesthesia Hypertension Market: Market Snapshot
Figure 10 LAMEA Inhalation Anesthesia Hypertension Market: Market Snapshot
Figure 11 Market Share/Ranking : Financial Snapshot
Figure 12 Halocarbon Products Corporation; : Financial Snapshot
Figure 13 Hikima Pharmaceuticals PLC : Financial Snapshot
Figure 14 Lunan Pharmaceutical Group Co. Ltd. : Financial Snapshot
Figure 15 Piramal Enterprises Limited : Financial Snapshot
Figure 16 Jiangsu Hengrui Medicine Co. Ltd. : Financial Snapshot
Figure 17 Fresenius Kabi AG : Financial Snapshot
Figure 18 AbbVie Inc. : Financial Snapshot
AbbVie Inc.
Fresenius Kabi AG
Halocarbon Products Corporation;
Hikima Pharmaceuticals PLC
Jiangsu Hengrui Medicine Co. Ltd.
Lunan Pharmaceutical Group Co. Ltd.
Piramal Enterprises Limited
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
